Abstract
Background
Continuous end tidal carbon dioxide (ETCO2) monitoring provides a noninvasive, real-time assessment of ventilation, pulmonary perfusion, and indirectly cardiac output. Although historically limited to anesthetic practice, capnography has emerged as an increasingly valuable physiologic monitoring tool in critical care settings.
Methods
A review was conducted using MEDLINE/PubMed and the Cochrane Library from 1988 to 2025 to evaluate the clinical applications of ETCO2 monitoring in critically ill patients. Eighteen studies met predefined inclusion criteria after screening and were included. Data were narratively synthesized.
Results
ETCO2 monitoring reliably reflects cardiopulmonary resuscitation quality and return of spontaneous circulation. In shock states, low ETCO2 correlates with elevated lactate, transfusion requirements, and mortality, serving as a rapid bedside marker of systemic hypoperfusion. Dynamic changes in ETCO2 during passive leg raising may predict fluid responsiveness in septic and cardiogenic shock. In ventilated or sedated patients, capnography enables earlier detection of hypoventilation and airway compromise.
Conclusions
ETCO2 monitoring is a physiologically informative, underutilized tool in critical care. When integrated in clinical context, capnography may enhance resuscitation quality, guide hemodynamic management, and improve ventilatory safety. Further prospective studies are needed to establish standardized ETCO2-guided resuscitation protocols.
Keywords
Get full access to this article
View all access options for this article.
